Here is a fact that should be common knowledge and is not: there are FDA-approved medications that measurably help people stop or reduce drinking—one of which can cut the reward out of alcohol itself—and only a small fraction of the millions of Americans with alcohol use disorder are ever offered them. No pill replaces treatment. But for a disorder where “just use willpower” remains the default prescription, the medication options deserve a fair, clear hearing. Here are the three approved drugs, how each works, who benefits, and how they fit inside real treatment.
Key Takeaways
- Three FDA-approved medications exist for alcohol use disorder—and only a small fraction of patients are ever offered them.
- Naltrexone mutes the reward and can start while still drinking; acamprosate steadies post-acute sobriety; disulfiram enforces commitment.
- None of the three is addictive, and none conflicts with AA, SMART, or therapy—combination is the intended use.
- Daily drinking still means medical detox first: the withdrawal risks do not care what medication comes later.
Naltrexone: Muting the Reward
Naltrexone blocks the opioid receptors through which alcohol delivers a meaningful part of its pleasure and reinforcement. On naltrexone, drinking still intoxicates but rewards less—the warm glow dims, the second drink argues less persuasively for the third—and craving intensity drops for many people. It comes as a daily tablet or the monthly Vivitrol injection (the same medication covered in the opioid comparison, which is why it double-serves people with both disorders). Evidence: consistent reductions in heavy-drinking days and relapse to heavy drinking. Notable flexibility: it can be started while still drinking, and the targeted-dosing approach (taking it an hour before drinking occasions—the Sinclair method) has evidence for gradually extinguishing the habit loop in people not ready for abstinence. Cautions: significant liver disease requires medical judgment, and it blocks opioid pain medication—surgical planning matters.
Acamprosate: Steadying the Post-Acute Brain
Acamprosate (Campral) works on the glutamate system that chronic drinking pushed out of balance—the same imbalance behind post-acute withdrawal: the insomnia, anxiety, restlessness, and dysphoria that make month two so dangerous. Started after abstinence is established (typically post-detox), it measurably improves the odds of staying abstinent, essentially by making sobriety more physiologically livable. It is taken three times daily—a real adherence consideration—is cleared by the kidneys rather than the liver (useful when liver disease rules other options out), and has a benign side-effect profile. Best fit: the person committed to abstinence whose early sobriety keeps being sabotaged by the way early sobriety feels.
Ready to talk? Admissions is available around the clock. Call (678) 904-8617 or verify your insurance online in under a minute. All calls are free and confidential.
Disulfiram: The Deliberate Deterrent
Disulfiram (Antabuse), the oldest of the three, blocks alcohol metabolism at the acetaldehyde step: drinking on it produces flushing, pounding headache, nausea, vomiting, and racing heart within minutes—an engineered consequence that makes drinking impossible to do casually. It does nothing for craving; its entire mechanism is commitment enforcement, which is why the evidence is strongest under supervised dosing—a spouse, clinic, or monitoring program witnessing the daily dose. For the right person—highly motivated, structure-responsive, with someone in the loop—it works; taken privately by an ambivalent person, it simply gets skipped on the day the decision fails. Honest cautions apply: the reaction is medically real, hidden alcohol (sauces, mouthwash) can trigger it, and cardiac and liver history need screening.
What’s Off-Label and On the Horizon
Clinicians also reach, with evidence of varying strength, for topiramate and gabapentin (craving and sleep, respectively—gabapentin with misuse-potential caveats), and baclofen in specific cases. None is FDA-approved for alcohol use disorder; all belong in a physician-managed plan, never self-assembled. The larger point stands regardless of agent: medication for alcohol use disorder is ordinary, evidence-based medicine—the same sentence nobody disputes about blood pressure—and declining to mention it to patients is the actual deviation from the standard of care.
Asking Your Doctor—or Us—the Right Way
If this page is the first you have heard of these options, the conversation to have is short: “I want to talk about medication for alcohol use disorder—naltrexone specifically. Is there a reason it would not be appropriate for me?” Framed that way, the burden sits where it belongs. A prescriber unfamiliar with the medications is common and fixable—addiction medicine and psychiatry handle these daily, and so do we. Bring your drinking pattern honestly (the high-functioning checklist helps structure it), your liver history if known, and your actual goal, abstinence or reduction—the medication choice follows from it.
How Medication Fits Real Treatment
Every trial behind these medications tested them alongside counseling, and that is how they work here. The sequence at Promises Atlanta: safe medical detox first where daily drinking has established dependence—the withdrawal risks do not care what medication comes later; then medication selection out of the assessment—naltrexone, acamprosate, or disulfiram matched to your goals (abstinence versus reduction), health picture, adherence reality, and the co-occurring conditions that get their own treatment in parallel; then the actual work—CBT, residential programming, family involvement, community—with the medication quietly lowering the difficulty setting underneath. If drinking has been winning every negotiation lately, this is a genuinely different negotiating position: call (678) 904-8617 or verify insurance online, and ask us the medication question directly. We will give you the same straight answer this page just did.
Frequently Asked Questions
Why have I never heard of these medications?
Underprescription is the scandal of the field: only a small fraction of people with alcohol use disorder are ever offered medication, despite decades of evidence. Stigma, outdated training, and the myth that willpower is the only legitimate tool all contribute.
Do I have to quit drinking before starting naltrexone?
No—naltrexone can be started while still drinking, and one evidence-based approach (the Sinclair method) uses it exactly that way, taken before drinking to gradually extinguish the reward. Acamprosate, by contrast, works best begun after abstinence is established.
Will these medications make me sick if I drink?
Only disulfiram is designed to—it creates an intensely unpleasant reaction to alcohol as a deterrent. Naltrexone and acamprosate do not punish drinking; naltrexone mutes its reward and acamprosate steadies the post-acute brain.
Are these medications addictive?
No. None of the three FDA-approved options—naltrexone, acamprosate, disulfiram—has abuse potential or produces dependence.
Can I take them alongside therapy and AA?
That is exactly the intended use: medication plus counseling outperforms either alone, and none of these conflicts with mutual support programs. Call (678) 904-8617 to sort which fits your picture.
Helpful Resources
- National Institute on Alcohol Abuse and Alcoholism — research-based information on alcohol use disorder
- Rethinking Drinking (NIAAA) — self-assessment tools and drink-counting calculators
- SAMHSA National Helpline (1-800-662-4357) — free, confidential, 24/7 treatment referral service
- Verify your insurance with Promises Atlanta — takes under a minute, free and confidential
